Cervical cancer is a notable public health concern for Kentucky, particularly the rural and Appalachian regions of the state. As reported by the Kentucky Cancer Registry, from 2002-2006, the state incidence rate for cervical cancer was 9.44 per 100,000 (ranked 5th highest in the US); rural counties’ incidence rate was 10.40 and the Appalachian region’s rate was 11.09.
The broad, long-term goal of Cervical Cancer-Free Kentucky Initiative is to impact cervical cancer disparities in Kentucky through prevention of Human Papillomavirus (HPV) infection, timely screening and diagnosis, access to follow-up care and treatment, and changes in cervical cancer-related health policy.
Through the coordination of existing state and local resources and collaboration of partners and organizations dedicated to the elimination of cervical cancer in the Commonwealth, the Cervical Cancer-Free Kentucky Initiative will help reduce cervical cancer incidence, morbidity and mortality; improve quality of life; decrease health care costs; and ultimately, impact overall cancer disparities in the state. This Cervical Cancer-Free Kentucky Initiative is made possible by an unrestricted gift from GlaxoSmithKline.